LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹581 Cr |
Mar2023 | ₹510 Cr |
Mar2022 | ₹472 Cr |
Mar2021 | ₹424 Cr |
Mar2020 | ₹386 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹581 Cr | 13.76 | |
Mar2023 | ₹510 Cr | 8.09 | |
Mar2022 | ₹472 Cr | 11.30 | |
Mar2021 | ₹424 Cr | 9.75 | |
Mar2020 | ₹386 Cr | - |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,141.3 Cr | -4.2% | -6.4% | -8.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,326.0 Cr | -2.3% | -3.5% | 9.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,562.0 Cr | -2.8% | 1.3% | 42.3% | Stock Analytics | |
CIPLA | ₹121,023.0 Cr | -0.3% | 3% | -2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,558.0 Cr | -3.7% | 7.2% | 8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,204.0 Cr | -1% | -0.5% | 13.2% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -4.2% |
-6.4% |
-8.1% |
SENSEX | -1.3% |
-0.8% |
6.3% |
You may also like the below Video Courses